AdAlta’s asset pipeline is growing rapidly
AdAlta’s initial pipeline of CAR-T assets (under exclusive negotiation) features high-value assets targeting lung, colorectal, gastric cancer, and other solid tumours, leveraging advanced CAR-T technologies.
The potential inherent in AdAlta’s “East to West” strategy
